National Development Bank PLC disclosed an LKR 13.2 billion internal fraud in April 2026 — initially estimated at LKR 380 million before being revised upward 35× in four days. FY 2025 audited PAT was restated from LKR 11.0B down to LKR 5.9B. CET1 dropped 183 bps in one quarter to 9.52%. Thirty days after the fraud disclosure, NDB sold 91.8% of its strategic stake in fellow CSE-listed Seylan Bank for LKR 2.77 billion — a CET1-eligible capital action that public commentary keeps mis-identifying as a Sampath Bank transaction. This dossier walks through the restatement mathematics, the CBSL probationary regime, and what the disposal actually means.
Right transaction, wrong bank. NDB did sell a strategic stake in a fellow CSE-listed Licensed Commercial Bank — but the bank was Seylan Bank PLC (SEYB.N0000), not Sampath Bank. Per the CSE corporate disclosure signed by Director/CEO Kelum Edirisinghe on 11 May 2026: NDB disposed of 26,631,495 voting shares in Seylan Bank at LKR 104 per share, generating proceeds of approximately LKR 2.77 billion. The transaction was executed on the CSE trading floor and framed in the disclosure as an exit from "a non-strategic investment upon identifying a suitable opportunity."
Pre-disposal, NDB held 29,023,151 Seylan voting shares — 9.508% of Seylan's voting capital, making NDB the 4th largest voting shareholder of Seylan Bank, larger than Sampath Bank's 9.357% holding. After the disposal, NDB retains roughly 2.39 million shares (~0.78%), which is why NDB no longer appears in Seylan's top 20 list once that list refreshes for Q2 2026 disclosures.
NDB and Sampath Bank have no cross-shareholding. The confusion in public commentary appears to mix three separate signals: (i) Sampath being mentioned by Financial Chronicle and NewsLine as a possible transactional channel in the fraud payment routing (CBSL has stated no other regulated institution suffered a loss), (ii) Y.S.H.I. Silva personally holding both 4.09% of NDB and 9.98% of Sampath in his individual capacity, and (iii) the actual NDB → Seylan stake disposal recorded above.
The disposal happened 30 days after the fraud was disclosed publicly (6 April), 11 days after Q1 2026 interim results showed CET1 at 9.52% (30 April), and 44 days before Q2 2026 capital ratios are reportable. The timing is the story. "Non-strategic investment upon identifying a suitable opportunity" is corporate language for a position the Bank chose to monetise under regulatory probation, in a quarter where the next CET1 print matters more than usual.
The capital quality angle is the most important detail. The March 2026 GSS+ Bond (LKR 16B) went into Tier 2 — useful for Total CAR but contributes nothing to CET1. The May 2026 Seylan disposal generates a realised gain on a fair-value-through-OCI equity holding, which flows through retained earnings into CET1 directly. CET1 is the ratio Fitch is watching for a further downgrade, and the buffer over the 7.0% minimum was only 252 bps at Q1'26. NDB needs CET1 specifically — and a strategic-stake disposal is one of the few legal tools available to generate it without shareholder dilution.
Proceeds of LKR 2.77B cover roughly 21% of the LKR 13.2B fraud loss. This is not a fire-sale for liquidity — NDB's deposit base is stable and LCR remains compliant. This is a deliberate capital quality manoeuvre, executed quietly on the trading floor.
| Position | Shares | % of Voting | Status |
|---|---|---|---|
| Before disposal (Annual Report FY25) | 29,023,151 | 9.508% | 4th largest voting shareholder |
| Disposed on 11 May 2026 | (26,631,495) | (8.724%) | Block trade @ LKR 104 |
| Remaining (implied) | 2,391,656 | 0.784% | Below top-20 threshold |
The LKR 16B GSS+ Bond raised in March 2026 was a Tier 2 instrument. It boosted Total CAR but contributes zero to CET1 (Common Equity Tier 1). CET1 is the highest-quality, loss-absorbing tier of regulatory capital — and the ratio that determines whether a Bank stays out of corrective-action territory.
At Q1 2026, NDB's CET1 buffer over the 7.0% regulatory minimum was just 252 bps. Tier 1 buffer over the 8.5% minimum was 102 bps. A second restatement or any material credit event could compress these buffers further. The Bank needs CET1 specifically.
The Seylan holding sat in NDB's FVOCI portfolio (Fair Value Through Other Comprehensive Income) — per the Q1 2026 interim, Level 1 quoted FVOCI equity instruments totalled LKR 86.45B. Unrealised gains on FVOCI equities accumulate in the Fair Value Reserve within Other Reserves, outside CET1.
When the position is sold, the realised gain (proceeds minus carrying value) is reclassified from the Fair Value Reserve into Retained Earnings — and retained earnings are a direct component of CET1 capital. The disposal is therefore a CET1-positive event, even if the proceeds (LKR 2.77B) look small relative to the LKR 13.2B fraud.
With Q1 2026 Risk-Weighted Assets implied at approximately LKR 588B (Total Capital 90.6B ÷ 15.41% Total CAR), every LKR 1B added to CET1 lifts the CET1 ratio by approximately 17 bps. The exact CET1 boost depends on the carrying value of the Seylan stake at the start of the quarter and the realised gain.
If the average carrying value was LKR 70 per share, the realised gain is roughly LKR 0.9B, lifting CET1 by ~15 bps. If carrying was LKR 50 per share, the gain is LKR 1.4B, lifting CET1 by ~24 bps. The gross proceeds also reduce off-balance-sheet equity exposure, slightly improving RWAs. The disposal could move CET1 from 9.52% to roughly 9.75–9.95% at the next reporting date, assuming no other moving parts.
A trading-floor crossing at this scale is a pre-arranged transaction with a known counterparty — likely an institutional buyer or a strategic acquirer. Pre-disposal, Seylan's top 5 voting shareholders were: Sri Lanka Insurance Corp (15%), Brown & Company PLC (13.87%), EPF (9.86%), NDB (9.508%), Sampath Bank (9.357%).
Brown & Co + LOLC Investments together already hold ~23.24% of Seylan and have board representation. If they absorbed the NDB block, the LOLC group's combined stake would rise meaningfully — a control-shift threshold worth tracking. Alternatively, the buyer could be Sampath Bank itself (already at 9.357%), the state-owned institutions, or a single new strategic investor. The buyer's identity will surface in Seylan's next public top-20 list. This is the most important follow-up question raised by the 11 May disclosure.
| Investor KPI | FY25 As Reported | FY25 Restated | Q1'26 Reported | Q1'26 Ex-Fraud |
|---|---|---|---|---|
| EPS Annualised (LKR) | 25.90 | 13.64 | 23.17 | 26.51 |
| Return on Equity (%) | 13.49 | 7.48 | 12.61 | 13.36 |
| Return on Avg Assets pre-tax (%) | 2.47 | 1.37 | 2.14 | 2.39 |
| Net Interest Margin (%) | 4.04 | 4.06 | 3.86 | 3.86 |
| Cost / Income Ratio (%) | 41.04 | 61.70 | 59.07 | 38.17 |
| NAV per Share (LKR) | 201.51 | 188.30 | 183.78 | — |
| Line Item (Bank, LKR '000) | As Reported FY24 | Adjustment | Restated FY24 | As Reported FY25 | Adjustment | Restated FY25 |
|---|---|---|---|---|---|---|
| Other Assets | 7,066,842 | (914,505) | 6,152,337 | 16,259,404 | (9,642,574) | 6,616,830 |
| Current Tax Liabilities | 5,204,643 | (268,748) | 4,935,895 | 4,038,962 | (3,095,503) | 943,459 |
| Other Liabilities | 10,860,883 | (153,178) | 10,707,705 | 11,215,309 | (911,012) | 10,304,297 |
| Retained Earnings | 43,501,856 | (492,579) | 43,009,277 | 50,334,623 | (5,636,059) | 44,698,564 |
On 18 March 2026, the Board approved a final FY25 dividend of LKR 8.50 per share (LKR 6.46 cash + LKR 2.04 scrip). On 6 April 2026 — the same day the cash component was scheduled to credit shareholder accounts — CBSL issued a directive suspending payment in light of the fraud disclosure.
The LKR 2.88 billion cash dividend now sits on the balance sheet as Dividends Payable, up from LKR 124 million at FY25-end — a 2,222% jump. The scrip portion proceeded as planned: 5.3 million ordinary shares were listed on the CSE on 10 April 2026.
CBSL directed NDB to restrict all discretionary payments and suspend branch expansion. These directives remain "in force until specifically varied by a decision of CBSL." For a Bank historically positioning itself for SME and corporate growth, these are meaningful franchise constraints — they affect bonus pools, marketing spend, network expansion plans, and the 2030 strategic agenda outlined by CEO Edirisinghe.
The Board commissioned Deloitte Touche Tohmatsu India LLP to conduct a forensic review, with findings reporting directly to CBSL rather than to NDB management. This governance architecture is unusual and tightens accountability. Per CBSL's 17 April statement, the audit scope extends to "any failures on compliance with regulatory requirements on control, oversight and governance during the period in which the fraudulent transactions took place" — implying scrutiny of both Bank and regulator behaviour.
NDB engaged KPMG as external auditor for FY 2026, replacing Ernst & Young who served through FY 2025. The transition is framed as compliance with Direction No. 6.2(d)(iv) of CBSL Banking Act Directions No. 5 of 2024 (audit firm rotation), but the timing — coinciding with the largest fraud restatement in NDB's history — invites scrutiny. EY signed off on FY 2024 and FY 2025 audits without detecting the fraud that has now been allocated retrospectively to both periods.
A shareholder derivative action filed in the Commercial High Court of Western Province (M. Thiyagarajah vs NDB & Others) names EY as a respondent alongside the directors.
Fitch Ratings Lanka moved NDB from "A(lka) / Stable" (FY 2025) to "A−(lka) / Negative Outlook" (Q1 2026). A Negative Outlook typically implies a more-than-even probability of further downgrade within 12–18 months. For a Licensed Commercial Bank, ratings directly affect wholesale funding costs, correspondent banking lines, and the pricing of any future Tier-2 issuance.
Independent Non-Executive Director Mr. Shanil Fernando — founding member of Virtusa Corporation and co-founder of Sysco Labs — resigned from the NDB Board with effect from 27 April 2026, mid-quarter and during the active CBSL/Deloitte forensic engagement. No reason was disclosed in the CSE announcement. A single director departure is not in itself definitive, but departures during regulatory investigations are statistically associated with governance disagreements.
The first CSE disclosure (2 April 2026) estimated fraud impact at LKR 380 million. The follow-up disclosure (6 April 2026) revised it to LKR 13.2 billion — a 35× revision. EconomyNext observed: "If the internal investigation was sophisticated enough to detect the fraud on April 2, the four-day delay in revealing the true Rs. 13.2 billion scale suggests that the bank may have been negotiating regulatory support with the CBSL behind closed doors before coming clean to the public."
The CID informed the Colombo Chief Magistrate's Court on 7 January 2026 that it had questioned several senior NDB officials including the Managing Director over a separate alleged LKR 290 million fraud from a general ledger account. NDB did not disclose this matter to the CSE as material information at the time. This raises serious questions about compliance with CSE Listing Rules on the immediate disclosure of material information.
Off-balance-sheet exposure (guarantees, performance bonds, documentary credits, undrawn commitments) jumped from LKR 403.0B at FY25-end to LKR 477.3B at Q1'26-end — an 18% QoQ increase. Domestic guarantees declined slightly, but foreign-currency guarantees grew 66% and documentary credits grew 30%. In a stressed franchise, growing contingent exposure adds tail risk.
Net cash from operating activities fell from LKR 33.05B (Q1'25) to LKR 3.61B (Q1'26). Strong core operating profit (+53.5%) was overwhelmed by loan book expansion consuming LKR 33.4B of cash. Deposit growth of 3% did not match. The funding gap was bridged by the GSS+ Bond and dividend suspension.
The LKR 16B Basel III Tier-2 GSS+ Bond was raised on a dual mandate per the prospectus: (a) strengthen Capital Adequacy Ratio, and (b) finance GSS+ (green, social, sustainability) projects within 24 months. Per Q1'26 disclosure, objective (a) is 100% utilised; objective (b) is at 0% utilisation — "invested in the Bank's treasury liquidity portfolio." With CBSL restricting branch expansion and the franchise on regulatory probation, the realistic deployment timeline for the impact-mandated portion is in question.
NIM: 4.34% (FY24) → 4.06% (FY25 restated) → 3.86% (Q1'26). Net Interest Income grew 13.5% YoY in Q1'26 even with interest rates compressing. The fraud sat in the operating expense/asset side, not in the loan or deposit book — earnings power from core intermediation is intact.
Stage 3 impaired loan ratio: 5.18% (FY24) → 3.75% (FY25) → 3.18% (Q1'26). Stage 3 coverage: 54.5% → 59.1% → 62.1%. Stage 2 stock dropped from 16.6% (FY24) to 6.7% (Q1'26). Loan impairment charges declined 33.4% YoY in Q1'26. The credit risk infrastructure is functioning even as the operational risk infrastructure failed.
Despite the restatement: CET1 9.52% (min 7.0%), Tier 1 9.52% (min 8.5%), Total CAR 15.41% (min 12.5%), Leverage 5.47% (min 3.0%). The buffers are compressed but positive. CBSL has explicitly stated NDB's "core financial strength" is not affected by the incident.
Total deposits grew from LKR 707.2B (FY25-end) to LKR 731.7B (Q1'26-end) — +3.5% in the quarter where the fraud was disclosed. CBSL confirmed customer balances are unaffected. Net loans-to-deposits ratio at 85.2% — conservative. The reputational damage has not transmitted into a funding crisis.
Loans to the SME sector reached LKR 131.7B at Q1'26-end, up LKR 7.1B over end-2025. The Bank's franchise position in SME — which it has prioritised strategically — appears not visibly damaged by the disclosure. Net fee and commission income grew 24.9% YoY, suggesting customer engagement is intact.
The LKR 16B Basel III Tier-2 GSS+ Bond was issued 10 March 2026 and oversubscribed the same day — three weeks before the fraud disclosure. Wholesale fixed-income investors backed the issue. The proceeds materially supported the Total CAR ratio post-fraud restatement and have not required emergency capital action.
Deloitte reports findings directly to CBSL, not to NDB management. The scope explicitly covers both fraud mechanics and regulatory compliance lapses. This is a higher governance bar than most Sri Lankan corporate forensic engagements. CBSL's Lanka News Web statement (24 April) confirmed the regulator is "prioritising the forensic investigation before deciding whether to suspend the current board or appoint an interim Competent Authority" — that decision tree remains open.
1 · Who absorbed the Seylan block. 26.6M Seylan voting shares were crossed on the trading floor — this was a pre-arranged transaction with a specific counterparty. The buyer will surface in Seylan's next public top-20 list. If LOLC/Brown & Co absorbed it, their combined Seylan stake breaches new control thresholds. If a single new strategic investor took it, that's a new entrant on the Seylan board map. This is the single most actionable follow-up.
2 · Deloitte interim findings. Reports flow directly to CBSL. If the scope extends to regulatory lapses as advertised, this is the single most material event ahead.
3 · Derivative action progression. Outcomes around director removal, auditor liability, and quantum of recoveries could reset the governance picture.
4 · Recovery actions on the fraud sum. Any funds recovered will be recognised in future periods — partial reversals of the restatement remain possible.
5 · Q2 2026 interim. First post-disposal period. Watch for CET1 ratio movement and the gain-on-disposal amount in the equity bridge.
6 · CBSL determination on Competent Authority. Lanka News Web reported CBSL is "prioritising the forensic investigation before deciding whether to suspend the current board or appoint an interim Competent Authority." This decision tree remains open.
7 · Fitch ratings action. A Negative Outlook implies elevated downgrade probability; any further deterioration could trigger debenture covenant or wholesale funding consequences. The Seylan disposal modestly helps the CET1 picture Fitch is watching.
What public disclosures show today is a Licensed Commercial Bank with a strong core franchise, stable deposit base, and improving loan book quality — operating under formal regulatory probation following an 18-month internal control failure that produced an LKR 13.2 billion restatement, the dismissal of its long-standing audit firm, a derivative action from a shareholder, and now a strategic-stake disposal generating CET1-eligible capital.
The fraud was severe, the disclosure timeline was poor, and the capital ratios are meaningfully compressed. None of these change the underlying interest-income generation capacity. The damage is operational, reputational, and governance-related — not a liquidity or solvency event.
The retail-discourse question — "did NDB sell their Sampath stake" — had the right transaction wrong on the bank name. NDB did sell a strategic stake in a fellow CSE-listed peer bank: Seylan Bank, not Sampath. The disposal generated LKR 2.77B in proceeds, executed 30 days after the fraud disclosure, in a quarter where CET1 quality matters more than total CAR. NDB's exit from the 4th-largest voting shareholder slot at Seylan — selling 91.8% of the position — is the most material capital action since the GSS+ Bond, and the buyer's identity is the next disclosure worth tracking. The right framing: NDB is monetising portfolio holdings to rebuild CET1 quietly while the Deloitte forensic audit runs in the background. Whether that's enough depends on what Deloitte finds — and on what Q2 2026 interim shows when it lands.